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Abstract
Policy and decision making should be based on evidence, but translating evidence into policy and practice is often
sporadic and slow. It is recognised that the relationship between research and policy uptake is complex and that
dissemination of research findings is necessary, but insufficient, for policy uptake. Political, social, and economic
context, use of (credible) data and dialogues between and across networks of researchers and policymakers play
important roles in evidence uptake. Advocacy is the process of mobilising political and public opinions to achieve
specific aims and its role is crucial in mobilising key actors to push for policy uptake. Advocacy and research groups
(i.e. those who would like to see research evidence used by policymakers) may use different approaches and tools
to stimulate the diffusion of research findings. The use of mass- and social media, communication with study
participants, and the involvement of stakeholders at the early stages of research development are examples of the
approaches that can be employed to stimulate diffusion of evidence and increase evidence uptake. The Research
and Advocacy Fund (RAF) for Maternal and Newborn Health (MNH) worked within the health system context in
Pakistan with the aim of espousing the principles of evidence, advocacy, and dissemination to improve MNH
outcomes. The articles included in this special issue are outputs of RAF and highlight where RAF’s approaches
contributed to MNH policy reforms. The papers discuss critical health system issues facing Pakistan, including
service delivery components, demand creation, equitable access, transportation interventions for improved referrals,
availability of medicines and equipment, and health workforce needs. In addition to these tangible elements, the
health system ‘software’, i.e. the power and the political and social contexts, is also represented in the collection.
These articles highlight three considerations for the future: the growing importance of implementation research,
the crucial need for participation and ownership, and the recognition that policymaking can be ‘informed’ by rather
than ‘based-on’ evidence. The future challenge will be to continue the momentum RAF has created and to
welcome a new era of health, wealth, and growth for Pakistan.
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Research, dissemination, and advocacy for policy
uptake
Policy- and decision-making should be based on evi-
dence [1], yet, translating evidence into policy and
practice is often sporadic and slow [2]. In the United
Kingdom, the need for policymakers to increase their
reliability on evidence was debated and thus evidence-
based policymaking became popularised during the late
1990s, which coincided with calls for greater invest-
ment into research in health in resource-poor countries
[3, 4]. This lead to the creation of the Global Forum for
Health Research, aiming to expand the use of evidence
in policy, particularly for the benefit of resource-limited
countries. There has been growing understanding of
how to reduce the gap between what we know
(evidence) and what is being done (practice) in inter-
national health and development. The slow progress
towards the Millennium Development Goals (MDGs)
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has resulted in urgent calls to close the gap as demon-
strated in three key international meetings: the Mexico
Statement on Health Research in 2004, the World
Health Assembly resolution in 2005, and the Bamako
Call to Action on Research for Health in 2008. These
have all recognised the role of research in closing the
knowledge–practice gap and improving health out-
comes. Consequently, knowledge translation and imple-
mentation research have become buzzing fields of
research over the last decade.
The relationship between research and policy uptake is
complex; few people would now defend the simplistic
model of linear causality between the two and realisation
of its complexity is growing. According to Grimshaw et al.
[5], translation of knowledge into policy ensures that
“stakeholders are aware of and use research evidence to
inform their health and healthcare decision-making”. Con-
tributions from social or political science fields suggest
that three factors play important roles in influencing
policy uptake: (1) political, social, and economic contexts;
(2) utilisation of (credible) data; and (3) researcher and
policymaker networks [6]. A multiplicity of actors is
therefore involved in evidence uptake: policymakers,
programme implementers, healthcare providers, patients,
family members and other informal carers, researchers,
and the medical and pharmaceutical industries.
Advocacy is the process of mobilising political and
public opinions to achieve specific aims. Its role is cru-
cial in mobilising key actors to push for evidence uptake
and greater accountability. Advocacy groups or organisa-
tions include wide ranging groups of people with differ-
ing motives and purposes. For example, patient support
groups may be instrumental in highlighting the gaps in
treatment, care, and support to patients [7] which re-
quire changes, raising public awareness of specific dis-
eases (for early detection and treatment), combating
stigma and prejudice associated with certain diseases, or
advocating for human rights [8]. Professional associa-
tions may provide their expert opinions to influence or
‘educate’ policymakers and patients [9]. In international
health and development, international organisations,
civil society organisations, non-governmental organisa-
tions (NGOs), and even national governments have in-
fluenced both public awareness and policymaking. In
global health in particular, effective advocacy has been a
determining factor in bringing what were once invisible
health issues into global policy agendas [10-12].
Dissemination and diffusion of research findings is ne-
cessary for the transfer of evidence to practice and to in-
fluence policymaking [13]. Yet, dissemination by itself is
not sufficient for policy uptake. Different approaches and
tools need to be employed to stimulate the diffusion of re-
search findings and engage a broader group of constitu-
ents so that they cross the boundary between science and
politics or between scientists and lay people. The
approaches used by actors who generate evidence
(researchers or research institutions) include engaging
with mass- [14] and social media and communicating with
study participants [15], which is important as it empowers
local communities to make decisions about their own
health and to act upon them. Capacity-building of those
who would like to see research evidence used by policy-
makers (advocacy organisations) is also warranted to en-
sure that research findings are shared, with fair credibility
and without distortion and exaggeration, for ‘healthy’
knowledge translation, and to hold decision makers
accountable.
The health system: an essential backdrop for
improving maternal and newborn health (MNH)
outcomes
Once called a neglected tragedy as epitomised by
Rosenfield and Maine’s seminal article [16], maternal
mortality has now gained importance in the inter-
national health agenda, most notably in the form of the
maternal mortality ratio included as a highly visible indi-
cator to measure progress towards MDG-5. Closely re-
lated to maternal well-being is the health of the
newborn and child, the improvement of which is ad-
dressed by MDG-4. There is wide agreement that ‘we
know what works’ to avert maternal mortality and dis-
ability [17], but how to deliver effective interventions to
women who need them is a key topic still debated within
the global safe motherhood community. In order to
achieve this, a functioning health system that is able to
provide emergency obstetric care with a well-functioning
referral system has been called for [18, 19]. Functioning
health systems capable of improving health outcomes
and strengthening maternity care for mothers and their
children can only be achieved through adequate finan-
cing (to form a health system) as well as through the
linking of health, referral, and community services in
order to provide quality obstetric care within the health
system [19]. The six building blocks of a health system,
as defined by the World Health Organization, include
service delivery; health workforce; health information;
medical products, vaccines and technologies; financing;
and leadership and governance [20]. In addition to the
tangible elements of health systems, Sheikh et al. [21]
argue that ‘software’, such as values, norms, and power,
that “guide actions and underpin the relationships
amongst system actors and elements are also critical to
overall health system performance”.
The publication of this special issue has two main
aims: first, to highlight where our approaches have been
able to contribute to policy-uptake in Pakistan, and sec-
ond, to further contribute to the dissemination of evi-
dence from Pakistan, stimulating MNH policy and
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practice reforms. The nine research papers and the
third commentary included in this issue stem from pro-
jects funded by the Maternal and Newborn Health
Programme Research and Advocacy Fund (RAF), a
programme implemented within the health system con-
text in Pakistan and which aimed to espouse the princi-
ples of evidence, advocacy, and dissemination described
above.
RAF was set up as a grant fund in 2008 to work with re-
searchers and civil society organisations to influence pro-
poor policy and practice reform on MNH in Pakistan. In
addition to providing grants, RAF provided capacity build-
ing support to researchers and civil society organisations,
for example, technical advice during the proposal develop-
ment phase on research methods, advocacy strategies, and
gender and inclusion, and communication approaches.
The programme also held consultations and reviewed
gaps in evidence to identify topics for advocacy. Overall,
56 research and advocacy projects were funded, which
provided a range of evidence on critical MNH issues, in-
fluencing over 30 different policy and practice issues. In
addition to policy reforms documented in the special
issue, we witnessed RAF-funded projects contributing to
changes in health worker curriculum, legislation on
breastfeeding and nutrition being passed in Sindh, Punjab,
Balochistan, Khyber Pakhtunkhwa, and Azad Jammu and
Kashmir, and increased government commitments to fam-
ily planning targets in line with Family Planning 2020.
Profiling advances in research, advocacy, and
uptake of evidence in Pakistan
In the articles included in the special issue, critical
health system issues compromising MNH outcomes in
Pakistan are discussed, for example, service delivery
components, demand creation, equitable access, trans-
portation interventions for improved referrals, availabil-
ity of medicines and equipment, and health workforce
needs. In addition to these tangible elements, the
‘software’ of the health system, i.e. the power and the
political and social contexts, is also represented in the
collection.
The first two commentaries from Ghaffar et al. [22]
and Bhutta et al. [23] provide an overview of Pakistan
in terms of its contributions to global maternal and
child health policies and strategic options. Sarwar et al.
[24] discuss RAF-supported advocacy efforts relating to
misoprostol and chlorhexidine use. Despite the avail-
able evidence base on the use of misoprostol for treat-
ment and prevention of postpartum haemorrhage and
chlorhexidine for the prevention of newborn sepsis, the
availability and utilisation of these medicines was
limited in Pakistan. A group from Mercy Corps
identified the knowledge and practice gap by evidence
review and field consultation, before facilitating a
multi-stakeholder, consultative process involving pol-
icymakers, policy implementers, and opinion leaders.
Focused advocacy efforts resulted in a number of policy
gains such as the inclusion of the medicines in the es-
sential drug list throughout the country. The authors
call for continued focus on the scale-up of appropriate
use of chlorhexidine and misoprostol and the use of
multi-stakeholder forums for future policy initiatives.
Pakistan’s Community Midwives (CMW) programme
has introduced a new cadre of skilled birth attendants in
the community. Similar to Indonesia’s Village Midwives,
who had the right to establish private practices, Pakistan’s
CMWs were expected to establish private practices after
2 years of government financial support. Many Indonesian
village midwives abandoned public service in favour of the
more lucrative private practice and the maternal mortality
ratio stagnated; three papers examine this high profile ini-
tiative. Mumtaz et al. [25] used a population-based survey
in two districts in Punjab province to examine women’s
uptake of CMWs. They showed that individual character-
istics, such as education or socio-economic status, have
no direct bearing on use of a CMW in childbirth. What
emerged as an important factor was the context in which
a woman lived, suggesting that social norms and standards
of development may need to be challenged and changed
to enhance demand for skilled birth attendants. Zafar
et al. [26] assessed the relevance of the current CMW
programme policy and explored community members’
preferences regarding birthing place. Based on community
members’ responses to a hypothetical question about pre-
ferred birthing place, the authors argue that community
members prefer a birthing station, which is accessible
within their community and adequately equipped for
childbirth. After results of this study were disseminated
within Pakistan, the National Maternal, Newborn and
Child Health (MNCH) Programme introduced birthing
stations, changing the way the MNCH Programme is be-
ing delivered. A new initiative of training CMWs on fam-
ily planning service provision in rural settings is discussed
by Hameed et al. [27], by comparing the CMW delivery
model to one involving a network of private providers
who became franchises of a local brand, supported by
training and advertising. ‘Social franchising’ similar to
‘business franchising’ is a method of expanding service de-
livery points for social goals by influencing private sector
providers [28]. Using a quasi-experimental study design,
the study demonstrated that the two delivery models were
able to achieve high continuation rates of intra-uterine
contraceptive devices, a long-acting reversible contracep-
tive that is underutilised in Pakistan.
Contracting out is another method of quickly
expanding service availability. Zaidi et al. [29] used a
mixed methods approach to present comparative ad-
vantages of contracting out in provision of MNH care
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in Pakistan. Drawing on a household survey and
facility assessment data, the authors showed higher
utilisation of MNH care services in the catchment
population of rural health units contracted to an
NGO; however, the results suggest that the users were
largely the educated and the wealthy. The authors
argue that targeted measures to promote behavioural
changes and to increase demand are needed to have a
meaningful impact on utilisation of care in remote
settings.
Inequity in access and the barriers to Emergency
Obstetric and Newborn Care services in Sindh province
are discussed by Ansari et al. [30]. In addition to finan-
cial and geographical barriers, the authors highlight
unfavourable attitudes and practices of healthcare pro-
viders as important barriers to seeking care from public
sector hospitals. Further, they suggest that caste-,
religion-, and ethnicity-based discrimination operates at
public sector hospitals, leading women to seek care else-
where. Discrimination of certain groups of women at
public sector hospitals, compounded by the dual practice
of healthcare providers in the public and private sectors,
appears to work synergistically, diverting women to seek
care from private sector practitioners.
The issue of caste-based discrimination and social ex-
clusion is further discussed by Aziz et al. [31], who crit-
ically examined the influence of the political and social
contexts on community participation in Punjab. Using
various participatory rural appraisal tools, the authors
identified and examined social hierarchies and formal
and informal ‘spaces’ where health activities would take
place in rural communities. Their analysis showed that
programme planners’ predilection for notable commu-
nity leaders in gaining support for community-based
health programmes often results in the exclusion of vul-
nerable groups from health education. Caste-based
boundaries were less rigid amongst men. Health-related
information trickled down from higher to lower caste
men, while women of lower caste, impinged by the
rigid caste-based boundaries, experience barriers to
informal information exchange with women of the
better-off castes. As the structures and designs of
MNH programmes reinforced the existing power dy-
namics, the authors argue that the systematic factors
need to be carefully considered in designing MNCH
programmes and call for the redefining of programme
structures and strategies in favour of vulnerable popu-
lation groups.
Pivotal to the functioning of a good maternity health-
care system is a referral system. Mian et al. [32]
reviewed various transportation initiatives in Pakistan,
which aimed to improve patient referrals. They assessed
the potential of scaling up the interventions for im-
proved patient referrals. The appraisal to assess
scalability was based on seven criteria, including cred-
ibility of the intervention, relevance to population de-
mand, and easy transferability. Amongst four categories
of initiatives (i.e. community-based, facility-based, pub-
lic sector, and voucher schemes), the authors found that
community-based interventions had the potential for
scale-up because of the simple design and community
ownership and participation, which will ensure
sustainability.
Human resources, another important component of
a health system, are examined by Mir et al. [33] for
this special issue. High attrition of healthcare pro-
viders in rural areas is a critical issue facing the
health system in Pakistan. Drawing on the national
survey of public-sector healthcare providers, the au-
thors identified the factors associated with the health-
care providers’ willingness to leave government
services. The study found that healthcare providers
who are dissatisfied with performance review process
or salary and working in certain areas of the country
(such as Balochistan and Azad Jammu and Kashmir),
appear to be more willing to leave. The authors rec-
ommend the development of an incentivising mech-
anism to accommodate healthcare providers in harsh
working conditions as well as administrative reforms
to revise the performance evaluation system incorpor-
ating new job-based indicators.
We have included a short article by Majrooh et al. [34]
to demonstrate results of a facility assessment in Punjab
province. The study showed clear gaps in service
provision for antenatal care. The results have had a sig-
nificant impact in Punjab province as the government
revised the kits for CMWs based on findings from the
assessment. Data from a simple cross-sectional facility
assessment may be useful in demanding resources for
infrastructure and equipment needed for quality health-
care services.
Looking forward
We began this article by considering the essential and
interlacing influences of research, dissemination, and ad-
vocacy for policy uptake. Understanding of how these
groups of activities and actors can and should work
together has grown considerably in the last decade
[35, 36]. Simply conveyed by its name, the RAF was
established as an original and unique initiative in its
time, consequently playing an important role in bring-
ing research and advocacy together and helping to
bridge the gap between evidence and decision-making
by putting dissemination, communication, and advo-
cacy at the core of all of its activities.
The articles in this supplement highlight three consid-
erations for the future: the growing importance of imple-
mentation research, the crucial need for participation
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and ownership, and the recognition that policymaking
can be ‘informed’ by rather than ‘based-on’ evidence.
Implementation research
We are in a very different place in MNH today compared
to where we were two decades ago. The last 20 years has
seen a burgeoning of knowledge generation in ‘what
works’ in MNH, including clinical studies on technological
innovations and randomised controlled trials on complex
interventions [37-40]. Despite documented progress in re-
ducing maternal and child mortality, however, our failure
to make sufficient improvement is related to the lack of
knowledge in understanding ‘why’ and ‘how to’. This is
where implementation research comes to the forefront.
Implementation research has been acclaimed as a “power-
ful tool for capturing and analysing information in real
time, allowing for the assessment of performance, for ex-
ample, and facilitating health systems strengthening” ([41],
p. 8). It aims to capture information to explain what is
happening and why [42], especially for finding solutions to
complex problems in the ‘real world’ of programme im-
plementation and policymaking [43]. Qualitative and
mixed methods studies play an important role in ensuring
that the realities of people’s experiences are captured. In
prioritising the funding of implementation research (and
in particular, not only funding primary research using ran-
domised control trials, but focusing on mixed methods
and qualitative research studies [44]), RAF has made an
important start to developing a ‘research culture’ in
Pakistan. It is important to maintain this momentum for
the future.
Implementation research is not free from limitations
and challenges, however. It will certainly present the same
problems as other types of research, and most obviously,
findings of implementation research need to be taken up
by the implementers to close the gap between evidence
generated by the implementation researchers and prac-
tices. Efforts are still needed to improve methods of dis-
semination. Researchers and implementers must come
together to strategize to achieve the desired research
objectives. RAF’s experience suggests that engaging stake-
holders at the early stages of research development for the
identification of priority topics and preferred research
designs is important for policy uptake and increased own-
ership (which is discussed further below). In terms of
methodologies, implementation research is a relatively
new field. There is no consensus on optimal methodology
for implementation research and interdisciplinary/
multidisciplinary approaches are needed, drawing on
quantitative, qualitative, and mixed methods. Discipline-
specific questions (e.g. [45]) are also emerging. New
methods are developed/borrowed from other disciplines
[43]. Training of a new generation of researchers is needed
to tackle research questions arising in this new field.
Participation and ownership
In resource-constrained settings, there is a special
need to prioritise initiatives for research and advocacy
on contextually-relevant priorities. To do so, wide
and inclusive participation of stakeholders is necessary
[46, 47]. Participation can create openness, transpar-
ency, and accountability, creating a ‘pull’ for mutual
learning and discussion [48]. This opens out the possi-
bility of developing policy and having shared owner-
ship of decisions made. In addition, participation
allows identification of local priorities based on expert,
local knowledge. By empowering national stakeholders
to have greater ownership of the priorities for research
and advocacy, the chances of improving uptake of
findings into decision-making processes for future pol-
icy and programming are increased. The principles of
participation are reflected in the way RAF played a
role in opening dialogue between policymakers, re-
searchers, and advocates. As shown in this special
issue, a number of tangible changes to health policy
and practices have been made following dissemination
of results from RAF-funded research and advocacy
projects. RAF acted as a catalyst in its short life in
Pakistan.
We also acknowledge the limitations and challenges
associated with stakeholder participation and owner-
ship. When engaging with stakeholders, not everyone’s
view can be represented, as ‘stakeholders’ are non-
homogenous groups of people with differing motives
and purposes. Participation is a highly political process
where existing power relations may be reinforced [31].
Though often overlooked, it is important to engage
stakeholders at a local and community level, particu-
larly to feedback research findings to participants and
communities. RAF was able to play a part in facilitat-
ing participation to some extent: it acted as a bridging
organisation creating forums for dialogue or partner-
ing researchers with civil society (such as NGOs). By
supporting qualitative and mixed methods studies that
capture the voices of the poor, RAF supported the
‘participation’ of ordinary citizens [44].
Evidence-informed policymaking
Our paper began with the idea of evidence-based policy-
making. However, it is well recognised that policy is in-
fluenced by more than just evidence, with politics, lobby
groups, media, and chance playing a part [49,50]. The
types of evidence that are considered in policymaking
are varied. Multiple sources of knowledge and informa-
tion and various types of research-based evidence inter-
act with the belief and value systems of policymakers
and influence their decisions, sometimes in subtle and
indirect ways [51]. Organizational values and cultures
and decision-making processes vary from one setting to
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another; hence, contexts inevitably play a significant role
in how decisions are made. Making policy decisions
solely based on evidence may simply be an aspirational
goal. Understanding how evidence can inform policy-
making will help researchers identify types of research
evidence useful for policymakers and work together to
improve public health policies and eventually health out-
comes. This means that what has been done by RAF is
only a start and questions of how to build on its legacy
need to be considered before the gained momentum is
lost.
The future
There will be no quick fixes in tackling such complex is-
sues in the future of Pakistan. The building of robust
healthcare systems is an area where many low- and
middle-income countries have been underperforming
[52]. These systems will require stronger health infrastruc-
ture, more health workers, greater access to medical prod-
ucts, more responsive health services, and more equitable
access to these services. It has been estimated that the cost
for health system strengthening will be about $30bn annu-
ally for the next few decades. The upside is that such
funds can be sourced from a combination of aid and do-
mestic spending given the economic growth and product-
ivity of many low- and middle-income countries [53],
provided they increase their domestic health spending.
Impressive gains have been made in moving towards
reaching MDG-4 and −5. RAF, as well as the many
groups, academia, NGOs, and government programmes
not directly funded by RAF but which dared to step out-
side their comfort zone and embrace participation in
RAF’s aims, have made key contributions, as attested by
this collection of papers. The challenge for the future will
be to build on these foundations to welcome a new era of
health, wealth, and growth for Pakistan.
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